Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An update from Pharmaust Limited ( (AU:NUZ) ) is now available.
Neurizon Therapeutics Limited announced a change in its shareholder registry service provider from Computershare to Automic Pty Ltd, effective January 20, 2025. This transition is expected to enhance convenience and functionality for shareholders through Automic’s secure online investor portal, offering streamlined processes for managing holdings, updating personal details, and voting at company meetings, thereby improving the overall shareholder experience.
More about Pharmaust Limited
Neurizon Therapeutics Limited is a clinical-stage biotechnology company focused on developing treatments for neurodegenerative diseases. The company’s lead drug candidate, NUZ-001, aims to treat ALS, the most prevalent form of motor neurone disease, with a strategy to broaden its application to other neurodegenerative conditions through international collaborations and clinical programs.
YTD Price Performance: 22.22%
Average Trading Volume: 7,567
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: €48.76M
See more data about NUZ stock on TipRanks’ Stock Analysis page.
